Mutations in MYD88 have been studied extensively in lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia (LPL/WM) and diffuse large B-cell lymphoma (DLBCL), due to the relatively high frequency of MYD88 mutations in these neoplasms. The gene discussed is MYD88; the disease is lymphoplasmacytic lymphoma.